Skip to main content

Multimorbidity

0
Pipeline Programs
4
Companies
6
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

UNION therapeutics
UNION therapeuticsDenmark - Hellerup
4 programs
Multi-component Intervention PackageN/A1 trial
Multi-component InterventionsN/A1 trial
Multi-component intervention for smokersN/A1 trial
Multi-component intervention packageN/A1 trial
Active Trials
NCT06457009Active Not Recruiting7,400Est. Jun 2026
NCT06458218Active Not Recruiting7,400Est. Jun 2026
NCT06458205Active Not Recruiting7,400Est. Jun 2026
+1 more trials
Integrated Biosciences
Integrated BiosciencesCA - San Carlos
1 program
EBQI-ICN/A1 trial
Active Trials
NCT05050643Active Not Recruiting17Est. Dec 2026
Philips
PhilipsNetherlands - Amsterdam
1 program
Lifeline CareSage FlaggingN/A1 trial
Active Trials
NCT03126565Completed370Est. Nov 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
UNION therapeuticsMulti-component Intervention Package
UNION therapeuticsMulti-component Interventions
UNION therapeuticsMulti-component intervention package
UNION therapeuticsMulti-component intervention for smokers
Integrated BiosciencesEBQI-IC
PhilipsLifeline CareSage Flagging

Clinical Trials (6)

Total enrollment: 29,987 patients across 6 trials

NCT06457009UNION therapeuticsMulti-component Intervention Package

Impact of Multi-Component Intervention on Suspected Asthma Population

Start: Jun 2024Est. completion: Jun 20267,400 patients
N/AActive Not Recruiting
NCT06458218UNION therapeuticsMulti-component Interventions

Impact of Multi-component Interventions on Populations With Mental Health Symptoms and High-risk COPD

Start: Jun 2024Est. completion: Jun 20267,400 patients
N/AActive Not Recruiting
NCT06456996UNION therapeuticsMulti-component intervention package

Impact of Multi-Component Interventions on High Risk COPD Population

Start: Jun 2024Est. completion: Jun 20267,400 patients
N/AActive Not Recruiting
NCT06458205UNION therapeuticsMulti-component intervention for smokers

Impact of Multi-Component Interventions on High-Risk COPD Smokers

Start: Jun 2024Est. completion: Jun 20267,400 patients
N/AActive Not Recruiting

High-Risk Veteran Initiative

Start: Jul 2021Est. completion: Dec 202617 patients
N/AActive Not Recruiting
NCT03126565PhilipsLifeline CareSage Flagging

Evaluation of the Philips Lifeline CareSage Risk Assessment System

Start: May 2017Est. completion: Nov 2019370 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

4 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.